• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.

作者信息

Seiwert T Y, Foster C C, Blair E A, Karrison T G, Agrawal N, Melotek J M, Portugal L, Brisson R J, Dekker A, Kochanny S, Gooi Z, Lingen M W, Villaflor V M, Ginat D T, Haraf D J, Vokes E E

出版信息

Ann Oncol. 2019 Oct 1;30(10):1673. doi: 10.1093/annonc/mdz171.

DOI:10.1093/annonc/mdz171
PMID:31168601
Abstract
摘要

相似文献

1
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.OPTIMA：一项针对人乳头瘤病毒阳性口咽癌的II期剂量与体积递减试验。
Ann Oncol. 2019 Oct 1;30(10):1673. doi: 10.1093/annonc/mdz171.
2
Patient-reported quality-of-life outcomes after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal carcinoma: Findings from a phase 2 trial.人乳头瘤病毒阳性口咽癌降阶梯放化疗后患者报告的生活质量结局：来自 2 期试验的结果。
Cancer. 2018 Feb 1;124(3):521-529. doi: 10.1002/cncr.30954. Epub 2017 Oct 17.
3
Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.比较 HPV 阳性口咽鳞状细胞癌的标准剂量放疗与降低放疗剂量在确定性治疗中的作用。
Radiother Oncol. 2019 May;134:81-88. doi: 10.1016/j.radonc.2019.01.016. Epub 2019 Feb 4.
4
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives.人乳头瘤病毒阳性口咽癌的治疗降阶梯：正在进行的试验、关键问题及展望
Int J Cancer. 2015 Apr 1;136(7):1494-503. doi: 10.1002/ijc.28847. Epub 2014 Apr 4.
5
Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder.人乳头瘤病毒相关口咽癌的剂量递减：初步探索
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):986-8. doi: 10.1016/j.ijrobp.2015.09.002. Epub 2015 Nov 11.
6
Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.根据AJCC/UICC TNM标准对阳性口咽癌进行拟议的人乳头瘤病毒风险适应性分期的确认。
Cancer. 2016 Jul 1;122(13):2021-30. doi: 10.1002/cncr.30021. Epub 2016 Apr 25.
7
De-escalation treatment of human papillomavirus-positive oropharyngeal squamous cell carcinoma: an evidence-based review for the locally advanced disease.人乳头瘤病毒阳性口咽鳞状细胞癌的降阶梯治疗：局部晚期疾病的循证综述。
Curr Opin Oncol. 2018 May;30(3):146-151. doi: 10.1097/CCO.0000000000000441.
8
What are the implications of human papillomavirus status in oropharyngeal tumors for clinical practice?口咽肿瘤中人乳头瘤病毒状态对临床实践有何影响？
Curr Opin Otolaryngol Head Neck Surg. 2014 Apr;22(2):90-4. doi: 10.1097/MOO.0000000000000030.
9
Regional Radiation Therapy for Oropharyngeal Cancer in the HPV Era.人乳头瘤病毒（HPV）时代口咽癌的区域放射治疗。
Semin Radiat Oncol. 2019 Apr;29(2):126-136. doi: 10.1016/j.semradonc.2018.11.011.
10
Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.肿瘤体积作为 p16 阳性和 p16 阴性口咽癌患者接受根治性调强放疗的预后标志物。
Strahlenther Onkol. 2018 Aug;194(8):759-770. doi: 10.1007/s00066-018-1309-z. Epub 2018 May 17.

引用本文的文献

1
Is less more? Revisiting elective nodal irradiation in head and neck cancer.少即是多？重新审视头颈癌的选择性淋巴结照射。
Strahlenther Onkol. 2025 Jul 24. doi: 10.1007/s00066-025-02437-5.
2
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.口咽癌和下咽癌基于证据的诊断、治疗、预防及术后护理指南
Ger Med Sci. 2025 Jun 24;23:Doc03. doi: 10.3205/000339. eCollection 2025.
3
Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers: A Critical Narrative Review.
人乳头瘤病毒阳性宫颈癌与口咽癌的分子机制及临床差异：一篇批判性叙述综述
BMC Med. 2025 Jul 7;23(1):405. doi: 10.1186/s12916-025-04247-z.
4
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer.人乳头瘤病毒相关口咽癌中循环肿瘤HPV-DNA的早期动态变化与新辅助化疗及反应适应性降阶梯治疗
Clin Cancer Res. 2025 Aug 1;31(15):3150-3159. doi: 10.1158/1078-0432.CCR-25-0152.
5
Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer: The DEPEND Phase 2 Nonrandomized Clinical Trial.人乳头瘤病毒阴性头颈癌新辅助纳武单抗联合化疗后进行反应分层化放疗：DEPEND 2期非随机临床试验
JAMA Oncol. 2025 May 1;11(5):492-501. doi: 10.1001/jamaoncol.2025.0081.
6
Clinical prognostic factors to guide treatment strategy for HPV‑positive oropharyngeal cancer using treatment outcomes of induction chemotherapy: A real‑world experience.利用诱导化疗的治疗结果指导人乳头瘤病毒阳性口咽癌治疗策略的临床预后因素：一项真实世界经验。
Oncol Lett. 2024 Jun 21;28(2):391. doi: 10.3892/ol.2024.14524. eCollection 2024 Aug.
7
[Research progress in diagnosis and treatment of HPV-associated oropharyngeal squamous cell carcinoma].[人乳头瘤病毒相关口咽鳞状细胞癌的诊断与治疗研究进展]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Sep;37(9):734-739. doi: 10.13201/j.issn.2096-7993.2023.09.009.
8
Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study.诱导化疗后肿瘤体积缩减率是局部晚期头颈部鳞癌的预后因素：一项回顾性队列研究。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221107714. doi: 10.1177/15330338221107714.
9
Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.前瞻性研究评估诱导化疗和反应适应性治疗局部区域病毒相关口咽癌中游离 HPV DNA 的动态变化。
BMC Cancer. 2022 Jan 3;22(1):17. doi: 10.1186/s12885-021-09146-z.
10
Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.液体活检在头颈部癌症中作为多功能生物标志物的应用。
Br J Cancer. 2022 Feb;126(3):361-370. doi: 10.1038/s41416-021-01626-0. Epub 2021 Dec 7.